190 related articles for article (PubMed ID: 38712978)
1. Recent progress in chimeric antigen receptor therapy for acute myeloid leukemia.
Wang X; Zhang Y; Xue S
Ann Hematol; 2024 Jun; 103(6):1843-1857. PubMed ID: 38381173
[TBL] [Abstract][Full Text] [Related]
2. Chimeric antigen receptor T-cell therapy in childhood acute myeloid leukemia: how far are we from a clinical application?
Naik S; Velasquez MP; Gottschalk S
Haematologica; 2024 Jun; 109(6):1656-1667. PubMed ID: 38832421
[TBL] [Abstract][Full Text] [Related]
3. Developing Strategies to Improve the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia.
Guo S; Gao X; Sadhana M; Guo R; Liu J; Lu W; Zhao MF
Curr Treat Options Oncol; 2023 Nov; 24(11):1614-1632. PubMed ID: 37870695
[TBL] [Abstract][Full Text] [Related]
4. Immune effector cell-associated haematotoxicity after CAR T-cell therapy: from mechanism to management.
Rejeski K; Jain MD; Shah NN; Perales MA; Subklewe M
Lancet Haematol; 2024 Jun; 11(6):e459-e470. PubMed ID: 38734026
[TBL] [Abstract][Full Text] [Related]
5. Structural surfaceomics reveals an AML-specific conformation of integrin β
Mandal K; Wicaksono G; Yu C; Adams JJ; Hoopmann MR; Temple WC; Izgutdina A; Escobar BP; Gorelik M; Ihling CH; Nix MA; Naik A; Xie WH; Hübner J; Rollins LA; Reid SM; Ramos E; Kasap C; Steri V; Serrano JAC; Salangsang F; Phojanakong P; McMillan M; Gavallos V; Leavitt AD; Logan AC; Rooney CM; Eyquem J; Sinz A; Huang BJ; Stieglitz E; Smith CC; Moritz RL; Sidhu SS; Huang L; Wiita AP
Nat Cancer; 2023 Nov; 4(11):1592-1609. PubMed ID: 37904046
[TBL] [Abstract][Full Text] [Related]
6. Epitope base editing: Non-malignant stem cells are going undercover.
Saniei S; Wagenblast E
Cell Stem Cell; 2023 Nov; 30(11):1400-1402. PubMed ID: 37922877
[TBL] [Abstract][Full Text] [Related]
7. Chimeric Antigen Receptor (CAR) T Cell Therapy in Acute Myeloid Leukemia (AML).
Hofmann S; Schubert ML; Wang L; He B; Neuber B; Dreger P; Müller-Tidow C; Schmitt M
J Clin Med; 2019 Feb; 8(2):. PubMed ID: 30736352
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in CAR-T cell therapy for acute myeloid leukaemia.
Gao C; Li X; Xu Y; Zhang T; Zhu H; Yao D
J Cell Mol Med; 2024 May; 28(9):e18369. PubMed ID: 38712978
[TBL] [Abstract][Full Text] [Related]
9. Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
Marofi F; Rahman HS; Al-Obaidi ZMJ; Jalil AT; Abdelbasset WK; Suksatan W; Dorofeev AE; Shomali N; Chartrand MS; Pathak Y; Hassanzadeh A; Baradaran B; Ahmadi M; Saeedi H; Tahmasebi S; Jarahian M
Stem Cell Res Ther; 2021 Aug; 12(1):465. PubMed ID: 34412685
[TBL] [Abstract][Full Text] [Related]
10. Naturally selected CD7 CAR-T therapy without genetic editing demonstrates significant antitumour efficacy against relapsed and refractory acute myeloid leukaemia (R/R-AML).
Lu Y; Liu Y; Wen S; Kuang N; Zhang X; Li J; Wang F
J Transl Med; 2022 Dec; 20(1):600. PubMed ID: 36517851
[TBL] [Abstract][Full Text] [Related]
11. CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
Cui Q; Qian C; Xu N; Kang L; Dai H; Cui W; Song B; Yin J; Li Z; Zhu X; Qu C; Liu T; Shen W; Zhu M; Yu L; Wu D; Tang X
J Hematol Oncol; 2021 May; 14(1):82. PubMed ID: 34034795
[TBL] [Abstract][Full Text] [Related]
12. Integrating CAR T-Cell Therapy and Transplantation: Comparisons of Safety and Long-Term Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation After CAR T-Cell or Chemotherapy-Based Complete Remission in B-Cell Acute Lymphoblastic Leukemia.
Zhao YL; Liu DY; Sun RJ; Zhang JP; Zhou JR; Wei ZJ; Xiong M; Cao XY; Lu Y; Yang JF; Zhang X; Lu DP; Lu P
Front Immunol; 2021; 12():605766. PubMed ID: 34025637
[TBL] [Abstract][Full Text] [Related]
13. Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia.
Caruso S; De Angelis B; Del Bufalo F; Ciccone R; Donsante S; Volpe G; Manni S; Guercio M; Pezzella M; Iaffaldano L; Silvestris DA; Sinibaldi M; Di Cecca S; Pitisci A; Velardi E; Merli P; Algeri M; Lodi M; Paganelli V; Serafini M; Riminucci M; Locatelli F; Quintarelli C
J Hematol Oncol; 2022 Nov; 15(1):163. PubMed ID: 36335396
[TBL] [Abstract][Full Text] [Related]
14. Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer.
Cao Y; Efetov SK; He M; Fu Y; Beeraka NM; Zhang J; Zhang X; Bannimath N; Chen K
Arch Immunol Ther Exp (Warsz); 2023 Aug; 71(1):19. PubMed ID: 37566162
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
